Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Spring;4(2):113-9.
doi: 10.1111/j.1559-4572.2008.00044.x.

The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus

Henry N Ginsberg  1 , Paul R MacCallum
Affiliations
Review

The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus

Henry N Ginsberg et al. J Cardiometab Syndr. 2009 Spring.

Abstract

Both the metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) confer an increased risk of coronary heart disease and cardiovascular disease (CVD). As MS and T2DM become more prevalent, there will be an associated rise in the number of individuals with or at risk for CVD and its related disorders. One major underlying cause of CVD in patients with MS or T2DM is a characteristic form of atherogenic dyslipidemia. This article reviews the evidence that demonstrates that individuals with MS or T2DM are at increased risk for CVD and highlights atherogenic dyslipidemia as an important risk factor for the development of CVD in these individuals. In an accompanying article, current pharmacotherapies available for the management of atherogenic dyslipidemia in individuals with MS or T2DM are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimates of relative risk for cardiovascular disease (CVD) and diabetes reported in prospective studies in samples from the general population using definitions of the metabolic syndrome (MS) developed by the National Cholesterol Education Program (NCEP) (adapted from Ford, 200517) (A) Associations between MS (using the NCEP definition) and CVD. (B) Associations between MS (using the NCEP definition) and diabetes.
Figure 2
Figure 2
(A) Age-adjusted prevalence of coronary heart disease (CHD) in the US population older than 50 years according the presence of the metabolic syndrome (MS) and diabetes mellitus (DM) (adapted from Alexander et al, 200312). (B) Prevalence of patients with major cardiovascular disease events in all patients in the Treating to New Targets study by MS and DM status (adapted from Deedwania et al, 200620). *Hazard ratio for patients with MS and diabetes vs patients without MS or diabetes. †Hazard ratio for patients with MS without diabetes vs patients without MS or diabetes.
Figure 3
Figure 3
Incidence of coronary heart disease (CHD) per 1000 persons over a period of 6 years according to the high-density lipoprotein cholesterol (HDL-C) level (adapted from Assmann et al, 1996.
See this image and copyright information in PMC

References

    1. World Health Organization Obesity and Overweight: World Health Organization global strategy on diet, physical activity and health fact sheet. [Accessed September 16, 2005]. 2003. http://www.who.int.
    1. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci. 2006;331:166–174. - PubMed
    1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
    1. American Diabetes Association National Fact Sheet. 2005 [Accessed September 16, 2005]; Available at http://www.diabetesorg/diabetes-statisticsjsp.
    1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359. - PubMed